FUJIMI INCORPORATED FY2026 Q3 Earnings Report

Financial Highlights

• Net Sales: ¥51.45B
• Operating Income: ¥10.50B
• Net Income: ¥7.82B
• EPS: ¥104.70

Income Statement

Balance Sheet

Profitability Ratios

Year-over-Year Comparison

Share Information

Dividend Information

Segment Information

Full Year Forecast

---

AI Financial Analysis

Executive Summary

Verdict: Solid Q3 performance with double-digit operating income growth and resilient margins, tempered by extended working capital cycles and elevated construction-in-progress. Revenue rose 9.9% YoY to 514.5, while operating income increased 15.9% YoY to 105.0, outpacing top-line growth and demonstrating operating leverage. Gross profit reached 231.9 with a gross margin of 45.1%, up roughly 130 bps YoY. Operating margin improved to 20.4%, expanding about 104 bps YoY on disciplined cost control relative to gross profit growth. Net income was 77.7, up 6.9% YoY, with net margin at 15.1%, compressing by about 44 bps due to higher interest expense and a normalized tax rate. Ordinary income rose 10.1% YoY to 106.6, aided by interest income and modest FX gains exceeding FX losses. Interest coverage remains exceptionally strong at 141.9x, indicating manageable debt service despite a step-up in long-term loans. Balance sheet strength is notable with a current ratio of 323% and a quick ratio of 289%, supported by cash and deposits of 328.2. Asset base expanded significantly to 1,211.3, driven by PPE growth to 477.7 and construction-in-progress of 262.7. Equity increased to 820.1, keeping leverage conservative with D/E at 0.48x and debt/capital at 16.7%. However, working capital efficiency deteriorated: DSO at 107 days and DIO at 193 days drive a long cash conversion cycle of 239 days. Profit quality is otherwise stable with limited one-time items (extraordinary loss of 0.5) and a modest net FX tailwind. Dividend policy signals a high payout ratio of 75.6%, which is above typical sustainability thresholds and leans on balance sheet strength. Management’s full-year guidance implies continued mid- to high-single digit growth in revenue and operating income, consistent with Q3 momentum. The ongoing capex program (reflected in elevated CIP) supports capacity and technology upgrades, with near-term ROIC pressure likely until assets are placed into service. Overall, earnings momentum is healthy, liquidity is ample, and leverage is conservative, but working capital stretch and execution on large CIP are key watch items for cash flow and returns.

Profitability Analysis

ROE (9.5%) = Net Profit Margin (15.1%) × Asset Turnover (0.425) × Financial Leverage (1.48x). The largest change driver YoY is financial leverage, which increased as total assets expanded with higher PPE and CIP while equity also rose but at a slower pace, providing a modest ROE tailwind. Net profit margin was broadly stable with a slight compression (about -44 bps YoY) due to higher interest expense and a normalized tax rate, partially offset by improved operating margin. Asset turnover declined as the asset base grew faster than sales, reflecting capacity build-out ahead of revenue realization. Business rationale: significant capital investments (PPE +63.7% YoY, CIP at 55% of PPE) increase the denominator before full earnings contribution, temporarily depressing turnover. Sustainability: operating margin gains appear supported by gross margin expansion (+130 bps) and scale benefits; however, asset turnover may remain under pressure until new capacity ramps. SG&A grew 11.1% YoY to 126.9, slightly above revenue growth (9.9%), a mild negative operating leverage signal outside of gross margin gains. Net financial result remains small versus operating profit; interest burden ratio at 1.010 indicates minimal drag from financing costs.

Growth Assessment

Top-line growth of 9.9% YoY reflects healthy demand and price/mix that lifted gross margin to 45.1%. Operating income outgrew sales (+15.9% YoY), benefitting from gross margin expansion and contained overheads relative to gross profit. Ordinary income rose 10.1% YoY with modest support from interest income and limited FX net gains (approx. 0.51). Net income growth of 6.9% was moderated by higher interest expense and a 26.2% effective tax rate. The full-year forecast guides to revenue of 6,790 and operating income of 1,300, implying continued growth consistent with year-to-date trends. Margin outlook is constructive given higher-value product mix and scale, though working capital stretch may limit cash conversion near term. Investment-led growth is evident from the large CIP balance, suggesting capacity/technology projects that should support medium-term revenue and earnings. Execution on commissioning timelines and ramp curves will be the determinant for sustaining double-digit profit growth. FX impact remains modest relative to operating profit (~5%), indicating limited volatility from currency at current levels. Ordinary income trajectory aligns with the operating trend, pointing to largely recurring earnings quality. Extraordinary items remained negligible, supporting the stability of reported profit.

Financial Health

Liquidity is strong: current ratio 323% and quick ratio 289% indicate ample short-term coverage, with cash and deposits of 328.2 exceeding current liabilities of 204.0. Solvency is conservative: D/E at 0.48x and debt/capital at 16.7% are well within investment-grade thresholds. Interest coverage is robust at 141.9x, reflecting low interest burden relative to operating earnings. Long-term loans total 164.3, with current portion 10.71, suggesting limited near-term refinancing pressure; maturity mismatch risk is low given sizable cash and receivables of 151.1. Equity increased to 820.1, supporting capital intensity growth. PPE intensity stands high at 39.4% of total assets, consistent with ongoing expansion. Investment securities rose to 50.7, adding a modest financial asset buffer. No off-balance-sheet obligations were noted. Notwithstanding strong ratios, working capital intensity (high DSO/DIO) elevates the need for vigilant liquidity management as inventory and receivable conversion lag cash.

Notable B/S Changes

Intangible Assets: +7.07 (+79.2%) - Increased software/technology investments; enhances capability but raises amortization exposure. Property, Plant and Equipment: +185.85 (+63.7%) - Large capacity/technology expansion; near-term asset turnover dilution until ramp. Investment Securities: +15.61 (+44.5%) - Larger financial asset buffer; modest increase in market/valuation sensitivity.

Cash Flow Quality

OCF/Net income is not available; however, working capital metrics indicate pressure on cash conversion with DSO at 107 days and DIO at 193 days, driving a CCC of 239 days. Such elongated cycles typically weigh on operating cash flow relative to earnings and warrant close monitoring of collection and inventory discipline. Free cash flow assessment is constrained by lack of capex disclosure, but the balance sheet shows substantial CIP (262.7), implying elevated investment cash outlays. Inventory buildup and extended receivables increase risk of temporary cash shortfalls if demand softens. No signs of earnings reliance on one-time gains; extraordinary loss was small (0.52), and net FX impact was modest (~0.51). Absence of large asset sale gains supports recurring earnings quality. Sustained improvement in DSO/DIO will be key to aligning cash generation with reported profits.

Dividend Sustainability

Interim and year-end DPS of 36.67 each imply annual DPS of 73.34, translating to a payout ratio of approximately 75.6% against current-period earnings. This exceeds the <60% benchmark for conservative sustainability and leans on the company’s strong balance sheet and liquidity. With significant ongoing investment (high CIP), internal cash needs are elevated; therefore, dividend coverage will depend on maintaining operating momentum and improving cash conversion. Interest burden is low and leverage is moderate, providing headroom to support distributions in the near term. In the absence of free cash flow data, the combination of high payout and capex intensity suggests less flexibility if working capital remains extended. Policy appears focused on stable returns; monitoring payout relative to cash earnings and capex cadence is critical.

Risk Assessment

Business risks include Execution risk on large capital projects given CIP at 55% of PPE, potentially delaying revenue and margin realization, Demand cyclicality and mix shifts that could impact gross margins and operating leverage, Supply chain and lead-time risks reflected in high DIO (193 days), increasing obsolescence exposure.

Financial risks include Working capital stretch with DSO at 107 days and CCC at 239 days, pressuring operating cash flow, Higher leverage versus prior year due to increased long-term loans, albeit from a low base, Payout ratio at 75.6% reduces buffer for downturns during capex-intensive phase.

Key concerns include Receivables collection efficiency deterioration (DSO 107 days), Inventory accumulation (DIO 193 days) and potential obsolescence risk, Timely conversion of CIP to productive assets to protect ROIC and asset turnover.

Investment Implications

Key takeaways include Strong operating momentum: revenue +9.9% YoY, operating income +15.9% YoY, Margin resilience: gross margin +130 bps and operating margin +104 bps YoY, Net margin slightly compressed on higher interest and normalized tax, Balance sheet remains conservative with D/E 0.48x and current ratio 323%, Working capital efficiency is a clear headwind with CCC at 239 days, Capex pipeline substantial (CIP 55% of PPE), supportive of medium-term growth but near-term ROIC drag.

Metrics to watch include DSO, DIO, and CCC trajectory each quarter, CIP roll-in rate and commissioning timelines, Operating margin durability and SG&A growth vs revenue, Interest expense trend relative to long-term loan schedule, Dividend payout ratio vs cash earnings.

Regarding relative positioning, Within Japanese manufacturing peers, profitability profile is strong with a 20%+ operating margin and 15% net margin, while leverage is conservative. The company’s working capital cycle is longer than typical benchmarks, and its capital intensity is rising due to expansion projects, positioning it for growth but requiring disciplined execution to sustain ROE near 10%.